SCHEMBL5207288

SCHEMBL5207288

CCOC(=O)c1ccc(-c2nnc(-c3ccccc3[N+](=O)[O-])o2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.57
NPC1 O15118 6/20 0.57
RAB9A P51151 6/20 0.57
SMN1; SMN2 Q16637 6/20 0.57
HSD17B10 Q99714 5/20 0.57
TSHR P16473 2/20 0.57
POLB P06746 2/20 0.57
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
ALDH1A1 P00352 5/20 0.52
GAA P10253 1/20 0.52
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
NFKB1 P19838 1/20 0.49
MAPK1 P28482 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HTT P42858 2/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204029 0.82 NPC1 (0.64) MAPTNPC1RAB9ASMN1; SMN2POLB
SCHEMBL5206118 0.81 SMN1; SMN2 (0.61) MAPTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL4489440 0.76 NPC1 (0.69) MAPTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL29158993 0.75 TARBP2 (0.61) MAPTRAB9AHSD17B10ALDH1A1GAA
SCHEMBL20361981 0.75 TARBP2 (0.58) MAPTSMN1; SMN2HSD17B10ALDH1A1GAA
SCHEMBL29158785 0.74 TARBP2 (0.52) MAPTRAB9ASMN1; SMN2HSD17B10ALDH1A1
SCHEMBL11815776 0.74 NPC1 (0.57) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL5652491 0.74 ALDH1A1 (0.52) MAPTNPC1RAB9ASMN1; SMN2POLB
SCHEMBL21541935 0.74 TARBP2 (0.59) MAPTNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL30740865 0.74 TARBP2 (0.59) MAPTNPC1RAB9ASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223791-B2 Function regulator for retinoid relative receptor TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-05-29 US disclosed
US-20040157881-A1 Function regulator for retinoid relative receptor TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
EP-1405636-A1 FUNCTION REGULATOR FOR RETINOID RELATIVE RECEPTOR Takeda Chemical Industries, Ltd. (JP) 2004-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157881-A1 Function regulator for retinoid relative receptor RXRA, RARA, RARG MAPT 4855/4885NPC1 828/4885RAB9A 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.